| It’s never too early to plan for an unexpected delay in patient randomizations. |
| |
| The bad news: |
| |
| It’s no secret that more than 80% of clinical trials do not finish on time, and the primary cause is unfulfilled patient enrollment. According to the Center for Information and Study on Clinical Research Participation (CISCRP), nearly 50% of all clinical research sites under enroll or fail to enroll a single patient. |
| |
| The good news: |
| |
| Acurian has the experience to help you accelerate enrollment across your entire pipeline, both before enrollment starts or well into enrollment as the risk of a delay becomes more prominent. For many trial protocols, we can accelerate or optimize plans for enrollment at no risk to you, including no upfront fees, no pass-through costs, and pricing fixed per randomized patient. |
| |
| Let’s work together to head off any impending delays. Simply click the link below, complete the short contact form, and an Acurian associate will be in touch to discuss your current trial challenges, priorities, and how we can help. |
| |
| [Click here and we’ll contact you shortly] |
| |
| https://www.acurian.com/contact-us/ |
| |
| If you would prefer not to receive further emails from us, please email marketingreplies@acurian.com with the word “unsubscribe” in the subject. |
| |
